Hepatitis and Encephalitis due to Coxsackie Virus A9 in an Adult
Coxsackie virus infection most commonly manifests itself in the neonatal period as a multisystem disease. This life-threatening neonatal infection has been recently treated with a new anti-picornaviral drug, pleconaril. In contrast, in adults Coxsackie virus is an uncommon source of hepatitis, but C...
Main Authors: | Brigitte Moreau, Clare Bastedo, Rene P. Michel, Peter Ghali |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2011-10-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/333135 |
Similar Items
-
Coxsackie encephalitis in a child in Western India
by: Ira Shah, et al.
Published: (2017-01-01) -
Prevention measures and suppression of coxsackie virus infection in health institutions
by: Stanisavljević Sanja, et al.
Published: (2017-01-01) -
Coxsackie B virus myositis in a healthy young man with mumps co-infection
by: Michelle Mao, et al.
Published: (2023-01-01) -
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
by: De Clercq Erik, et al.
Published: (2003-12-01) -
Probable Transmission of Coxsackie B3 Virus from Human to Chimpanzee, Denmark
by: Sandra C. Abel Nielsen, et al.
Published: (2012-07-01)